CNTMF (CNTMF) Stock Price & Analysis
CNTMF (CNTMF) rose 0.00% to USD 0.02 as of July 25, 2026 at 06:10 UTC, according to Nexqual real-time market data.
CNTMF last closed at USD 0.02; the session ranged USD 0.03–0.03 on volume of 105 shares. Market capitalization is $15.31M, with a 52-week range of USD 0.02–0.09 (OQB). Source: Nexqual, July 25, 2026 at 06:10 UTC.
Key Statistics (as of July 25, 2026 at 06:10 UTC)
| Price | USD 0.02 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.02 |
| Open | USD 0.03 |
| Day Range | USD 0.03 – 0.03 |
| 52-Week Range | USD 0.02 – 0.09 |
| Volume | 105 shares |
| Market Cap | $15.31M |
| Exchange | OQB |
Technical Analysis (CNTMF)
Nexqual's technical model rates CNTMF "BUY" based on 4 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 06:10 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 50.44 (neutral) |
| vs SMA50 | Above (USD 0.02) |
| MACD | 0 (positive) |
Analyst Ratings (CNTMF)
Wall Street analysts rate CNTMF "None", per Nexqual as of July 25, 2026 at 06:10 UTC.
| Consensus Rating | None |
|---|
Earnings (CNTMF)
| Next Earnings Date | 2026-08-26 |
|---|
Source: Nexqual, July 25, 2026 at 06:10 UTC.
Financials & Fundamentals (CNTMF)
| Total Revenue | $81.67M |
|---|---|
| Revenue Growth (YoY) | -21.90% |
| Gross Margin | +19.46% |
| Operating Margin | -45.96% |
| Profit Margin | -96.32% |
| Current Ratio | 0.81 |
| Total Cash | $6.33M |
| Total Debt | $143.83M |
| Free Cash Flow | $-11.65M |
Source: Nexqual, July 25, 2026 at 06:10 UTC.
Financial Health Score (CNTMF)
Nexqual rates CNTMF's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 06:10 UTC.
| Growth | Solid — Revenue +11% YoY (annual) |
|---|---|
| Profitability | Weak — Gross margin 19%, operating -46% |
| Balance Sheet | Mixed — $6M cash vs $144M debt |
| Cash Flow | Weak — FCF negative: -$12M, burning cash |
| Efficiency | Mixed — No data |
Ownership (CNTMF)
| Insider Ownership | +36.89% |
|---|---|
| Institutional Ownership | +1.85% |
| Shares Outstanding | 613.26M |
| Float | 384.53M |
Source: Nexqual, July 25, 2026 at 06:10 UTC.
Leadership (CNTMF)
CNTMF is led by Matthew Mundy, Interim CEO & Chief Legal Officer, per Nexqual as of July 25, 2026 at 06:10 UTC.
| Interim CEO & Chief Legal Officer | Matthew Mundy |
|---|---|
| CFO & Corporate Secretary | Patricia Fonseca |
| Chief Operating Officer | Victor Bindi |
| Executive Chairman | William M. Smith |
Major Backers & Investors (CNTMF)
Notable institutional backers of CNTMF include AdvisorShares Trust-AdvisorShares Pure Cannabis ETF, AdvisorShares Investments, LLC, according to Nexqual as of July 25, 2026 at 06:10 UTC.
Active Investors
| Investor | Stake |
|---|---|
| AdvisorShares Trust-AdvisorShares Pure Cannabis ETF | 1.85% |
| AdvisorShares Investments, LLC | 1.85% |
Source: Nexqual, July 25, 2026 at 06:10 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FFNTF | 4Front Ventures Corp. | USD 0 | ▲ 0% |
| KHRNF | KHIRON LIFE SCIENCES CORP | USD 0 | ▲ 0% |
| AYRWF | AYR WELLNESS INC. | USD 0 | ▲ 0% |
| CXXIF | C21 Investments Inc. | USD 0.21 | ▼ 6.39% |
| MEDIF | Medipharm Labs Corporation | USD 0.06 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 06:10 UTC. This page is informational and not investment advice.